65184-39-6

Basic information

• Product Name: 5-ACETYLPYRIDINE-2-CARBOXYLIC ACID
• Synonyms: 5-ACETYLPYRIDINE-2-CARBOXYLIC ACID;5-Acetyl-2-pyridinecarboxylic acid;5-acetylpicolinic acid
• CAS NO: 65184-39-6
• Molecular Formula: C8H7NO3
• Molecular Weight: 165.15
• Mol File: 65184-39-6.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 5-ACETYLPYRIDINE-2-CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 5-ACETYLPYRIDINE-2-CARBOXYLIC ACID(65184-39-6)
• EPA Substance Registry System: 5-ACETYLPYRIDINE-2-CARBOXYLIC ACID(65184-39-6)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 65184-39-6(Hazardous Substances Data)

Usage

General Description

5-Acetylpyridine-2-carboxylic acid is a chemical compound with the molecular formula C8H7NO3. It is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 5-ACETYLPYRIDINE-2-CARBOXYLIC ACID is also known for its potential biological activities, including its use as a precursor in the production of bioactive molecules. It has been identified as a key component in the development of anti-inflammatory and anti-cancer drugs. Additionally, its unique structure and properties make it a valuable tool for researchers studying the structure-activity relationships of various chemical compounds.

Upstream product

• 249583-84-4 5-acetyl-2-pyridinecarbonitrile 
• 139042-59-4 1-(6-bromopyridin-3-yl)ethanone 
• 770-08-1 5-ethylpyridine-2-carboxylic acid 

Relevant articles and documents

Iminothiadiazine Dioxide Compounds as BACE Inhibitors, Compositions and Their Use

In its many embodiments, the present invention provides certain iminothiadiazine dioxide compounds, including compounds Formula (I): and include stereoisomers thereof, and pharmaceutically acceptable salts of said compounds stereoisomers, wherein each of R1, R2, R3, R4, R5, R9, ring A, ring B, m, n, p, -L1-, -L2-, and -L3- is selected independently and as defined herein. The novel iminothiadiazine dioxide compounds of the invention have surprisingly been found to exhibit properties which are expected to render them advantageous as BACE inhibitors and/or for the treatment and prevention of various pathologies related to β-amyloid (“Aβ”) production. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use in treating pathologies associated with amyloid beta (Aβ) protein, including Alzheimer's disease, are also disclosed.